The arrival of Avéli® in Panama opens a new stage in the targeted treatment of cellulite depressions. Dr. Rodrigo Domínguez Millán, a board-certified plastic surgeon in Mexico, visits the country to support the first cases and share practical experience with Panamanian specialists.
Cellulite can be associated with fibrous septa that pull beneath the skin and contribute to dimples. Avéli does not act only on the surface: it enables the professional to identify and focally release septa associated with each selected depression.
The device is introduced into subcutaneous tissue through a small incision. Its design helps locate the responsible septum, confirm the resistance associated with that band and perform a controlled release during the same procedure.
In-procedure confirmation gives the surgeon direct information about the treated septum. This approach seeks to reduce reliance on estimates based only on external appearance and support a depression-specific intervention.
For plastic surgeons in Panama, Avéli adds another tool within body-contouring surgery and aesthetic medicine. It may complement treatment strategies in selected adult women when cellulite depressions are associated with identifiable fibrous septa.
Clinical evidence submitted for U.S. authorization included a multicenter evaluation of safety and performance. The authorized U.S. indication concerns reducing the appearance of cellulite in the buttocks and thighs of adult women; local indications may vary with applicable regulation.
Dr. Rodrigo Domínguez Millán’s participation brings practical training and knowledge transfer to the technology’s introduction. He is listed with current certification by the Mexican Board of Plastic, Aesthetic and Reconstructive Surgery.
For Akromed, bringing Avéli to Panama reflects its commitment to introducing specialized medical technologies with information, training and local support. Individual assessment, realistic expectations and professional judgment remain essential when determining treatment suitability.